Patents by Inventor Michael A. Conrad

Michael A. Conrad has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6239962
    Abstract: An arc fault circuit breaker assembled such that electrical interconnections, i.e., electrical connections between compartments, are made without disassembling any previously assembled compartment. The arc fault circuit breaker comprises housings having compartments within. Electrically connected components having interconnecting components, i.e., components which provide electrical interconnections between compartments, are disposed within the compartments. The housings are assembled together to enclose the compartments. Interconnecting components within an enclosed compartment extend through openings in the housings to provide electrical interconnections to the next compartment to be assembled. Therefore, no disassembly of the enclosed compartment is necessary to make the interconnections.
    Type: Grant
    Filed: February 9, 1999
    Date of Patent: May 29, 2001
    Assignee: General Electric Company
    Inventors: Raymond Kelsey Seymour, Murali Magham, Fredic W. Glabau, Kevin Jay Fuhr, Michael Conrad Guerrette
  • Patent number: 6207671
    Abstract: The cycloalkano-pyridines are prepared by reacting corresponding cycloalkano-pyridine-aldehydes with suitable organometallic compounds or Wittig or Grignard reagents or reacting compounds of the cycloalkano-pyridine alcohols type with suitable bromine compounds, and optionally varying the functional groups accordingly. The cycloalkanopyridines are suitable as active compounds in medicaments, in particular in medicaments for the treatment of hypertipoproteinaemia and arteriosclerosis.
    Type: Grant
    Filed: March 8, 2000
    Date of Patent: March 27, 2001
    Assignee: Bayer Aktiengesellschaft
    Inventors: Gunter Schmidt, Arndt Brandes, Rolf Angerbauer, Michael Lögers, Matthias Müller-Gliemann, Carsten Schmeck, Klaus-Dieter Bremm, Hilmar Bischoff, Delf Schmidt, Joachim Schuhmacher, Henry Giera, Holger Paulsen, Paul Naab, Michael Conrad, Jürgen Stoltefuss
  • Patent number: 6069148
    Abstract: The cycloalkano-pyridines are prepared by reacting corresponding cycloalkano-pyridine-aldehydes with suitable organometallic compounds or Wittig or Grignard reagents or reacting compounds of the cycloalkano-pyridine alcohols type with suitable bromine compounds, and optionally varying the functional groups accordingly. The, cycloalkanopyridines are suitable as active compounds in medicaments, in particular in medicaments for the treatment of hyperlipoproteinaemia and arteriosclerosis.
    Type: Grant
    Filed: July 8, 1997
    Date of Patent: May 30, 2000
    Assignee: Bayer Aktiengesellschaft
    Inventors: Gunter Schmidt, Arndt Brandes, Rolf Angerbauer, Michael Logers, Matthias Muller-Gliemann, Carsten Schmeck, Klaus-Dieter Bremm, Hilmar Bischoff, Delf Schmidt, Joachim Schuhmacher, Henry Giera, Holger Paulsen, Paul Naab, Michael Conrad, Jurgen Stoltefuss
  • Patent number: 6054589
    Abstract: A novel process for the preparation of 2-chloro-benzimidazole derivatives of the formula ##STR1## in which A represents optionally halogenated alkylene having 1 or 2 carbon atoms,which process comprises reaction 1,3-dihydro-benzimidazol(ethi)ones of the formula ##STR2## in which X represents oxygen or sulphur,with phosphorus oxychloride.Novel 1,3-dihydro-benzimidazol(ethi)ones of the formula(II) and process for their preparation.
    Type: Grant
    Filed: July 17, 1998
    Date of Patent: April 25, 2000
    Assignee: Bayer Aktiengesellschaft
    Inventors: Michael Conrad, Lutz Assmann, Heinz-Jurgen Wroblowsky, Carl Casser, Dietmar Bielefeldt
  • Patent number: 6028200
    Abstract: A novel process for the preparation of 2-chloro-benzimidazole derivatives of the formula in whichA represents optionally halogenated alkylene having 1 or 2 carbon atoms,which process comprises reacting 1,3-dihydro-benzimidazol(ethi)ones of the formula ##STR1## in which X represents oxygen or sulphur,with phosphorus oxychloride.Novel 1,3-dihydro-benzimidazol(ethi)ones of the formula (II) and processes for their preparation.
    Type: Grant
    Filed: May 7, 1999
    Date of Patent: February 22, 2000
    Assignee: Bayer Aktiengesellschaft
    Inventors: Michael Conrad, Lutz Assmann, Heinz-Jurgen Wroblowsky, Carl Casser, Dietmar Bielefeldt
  • Patent number: 5917050
    Abstract: Alkoxytriazolinones of the formula (I) ?known for example as intermediates for preparing agrochemically active compounds! ##STR1## wherein R represents an alkyl group, an alkenyl group, an alkinyl group, a cycloalkyl group, a cycloalkylalkyl group, an aryl group or an arylalkyl group, any of which may be substituted, are prepared by reactinga) thioimidodicarboxylic diesters of the general formula (II) ##STR2## wherein R is as defined above and R.sup.1 represents an alkyl group, an arylalkyl group or an aryl group, any of which may be substituted, withb) hydrazine, hydrazine hydrate or an acid adduct of hydrazine.The reaction is conducted i) in the presence of a diluent and, optionally, in the presence of a basic reaction auxiliary, and ii) at temperatures between -10.degree. C. and +100.degree. C.
    Type: Grant
    Filed: February 11, 1998
    Date of Patent: June 29, 1999
    Assignees: Bayer Corporation, Bayer Aktiengesellschaft
    Inventors: Michael Conrad, Reinhard Lantzsch, Vijay C. Desai, Shekhar V. Kulkarni
  • Patent number: 5830908
    Abstract: The invention relates to the crystalline form of the hydrochloride of the compound (R)-(-)-2-{N-?4-(1,1-dioxido-3-oxo-2,3-dihydro-benzisothiazol-2-yl)-butyl! -aminomethyl}-chroman, which is present as a stable form at room temperature. The crystalline modification V of the hydrochloride is suitable in particular for the preparation of solid medicaments, in particular of medicaments for the treatment of neuronal degenerations.
    Type: Grant
    Filed: November 19, 1996
    Date of Patent: November 3, 1998
    Assignee: Bayer Aktiengesellschaft
    Inventors: Alfons Grunenberg, Oliver Brehm, Michael Conrad, Dietrich Seidel
  • Patent number: 5048009
    Abstract: Method and apparatus for determining the location of a broadcasting station in a local area network communications system such as Ethernet that is arranged in a bus topology. An echo module, positioned at one end of a cable, receives a packet broadcast by a station and broadcasts a distinctive echo pulse on the cable during the interframe gap or at another chosen time. A processor module positioned at a second end of the cable receives the originally broadcast packet and the echo pulse, notes the times of receipt t.sub.1 and t.sub.2, respectively, of these signals, and determines the temporal distance T.sub.1 from the broadcasting station to the echo module by the equationT.sub.1 =(t.sub.2 -t.sub.1 -.DELTA.t.sub.dp)/2,where .DELTA.t.sub.dp is a time delay associated with validation of the echo pulse.
    Type: Grant
    Filed: February 28, 1989
    Date of Patent: September 10, 1991
    Assignee: Hewlett-Packard Company
    Inventor: Michael Conrad